AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (462.1 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Clinical Research | Publishing Language: Chinese

Clinical characteristics of patients with essential hypertension complicated with persistent atrial fibrillation

Jiaqi Bai1, Ruizhe Li1,2, Mei Zhu1, Minglei Zhang1,3, Nana Yin1, Zongbin Li1,2,3( )
Department of Cardiology, The Sixth Medical Center, Chinese PLA General Hospital, Beijing 100037, China
Chinese PLA Medical School, Beijing 100853, China
Department of Clinical Medicine, School of Medicine, Nankai University, Tianjin 300071, China
Show Author Information

Abstract

Objective

To investigate the clinical characteristics of patients with essential hypertension complicated with persistent atrial fibrillation (EHP-PeAF).

Methods

A retrospective analysis was conducted of the clinical data of 384 EHP-PeAF patients who were hospitalized in the Department of Cardiology and Neurology of the Chinese PLA General Hospital from January 2010 to December 2019. Based on age, the patients were divided into five groups: ≤50 years (n=17), 50–60 years (n=59), 60–70 years (n=108), 70–80 years (n=144), and >80 years (n=56). The patients were also divided into quartiles based on the CHA2DS2-VASc score: Q1 group (≤1 point, n=43), Q2 group (2–3 points, n=131), Q3 group (4 points, n=71), and Q4 group (5–9 points, n=139). The demographic characteristics, laboratory indicators, comorbidities, and medication use were analyzed, and the patients were compared in gender, age, and CHA2DS2-VASc score. Data analysis was performed using R 4.5.2 statistical software. Comparisons between two groups were conducted using independent sample t tests, Mann-Whitney U tests, χ2 tests, or Fisher's exact probability method, and pairwise comparisons among multiple groups were corrected using the Bonferroni method. Trend analysis of ordinal categorical variables was performed using the Cochran-Armitage trend test.

Results

The median age of the patients was 71.00 (63.00, 77.00) years, the average body mass index (BMI) was (26.21±3.86) kg/m2, 62.00% patients were male, 38.50% had a history of smoking, and 38.00% had a history of drinking. Gender-stratified analysis showed that female patients had higher age, CHA2DS2-VASc score, high-density lipoprotein cholesterol, D-dimer, and prevalence of coronary artery disease (CAD) than male patients. Height, Body weight, BMI, alanine aminotransferase, creatinine, hemoglobin, and uric acid levels were lower in female patients, and the differences were statistically significant (all P<0.05). Among comorbidities, the prevalence of CAD was the highest (66.40%), followed by heart failure (HF, 38.30%) and stroke (CS, 32.80%). The prevalence of CAD, HF, CS, and peripheral arterial disease (PAD) increased significantly with age (all P for trend <0.05), and the prevalence of CAD in the 70–80 years and >80 years groups was significantly higher than that in ≤50 years group (P<0.005). The prevalence of HF, diabetes mellitus, CS, CAD, chronic kidney disease, and PAD increased significantly with the increase in CHA2DS2-VASc score (all P for trend <0.005), and the multiple comorbidity burden in the high-score group was significantly higher than that in the low-score group. In terms of medication use, 52.10% of the patients used at least one antihypertensive drug, including 151 patients (39.30%) on monotherapy and 49 (12.80%) on combine therapy (≥2 medications). Calcium channel blockers were the most commonly used antihypertensive drugs (31.50%), followed by angiotensin Ⅱ receptor blocker (20.60%). The usage rate of oral anticoagulant (OAC) was only 7.30%, indicating significant insufficiency in both antihypertensive and anticoagulant standardized treatment. OAC usage rate increased significantly with age, and the usage rates of other antihypertensive drugs decreased significantly with age (P for trend =0.024, 0.012). The usage rate of diuretics increased with the increase in CHA2DS2-VASc score (P for trend =0.047), while OAC usage rate did not significantly increase.

Conclusion

EHP-PeAF patients have a high incidence of cardiovascular comorbidities and receive insufficient anticoagulation and antihypertensive treatments. Clinically, it is necessary to standardize drug therapy and strengthen comprehensive management of comorbidities.

CLC number: R544.1 Document code: A

References

【1】
【1】
 
 
Chinese Journal of Multiple Organ Diseases in the Elderly
Pages 486-492

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Bai J, Li R, Zhu M, et al. Clinical characteristics of patients with essential hypertension complicated with persistent atrial fibrillation. Chinese Journal of Multiple Organ Diseases in the Elderly, 2026, 25(7): 486-492. https://doi.org/10.11915/j.issn.1671-5403.2026.07.100

3

Views

0

Downloads

0

Crossref

Received: 17 July 2025
Accepted: 18 September 2025
Published: 28 July 2026
© 2026 Chinese Journal of Multiple Organ Diseases in the Elderly